These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 6431428

  • 21. [Acquired hemophilia: current status in Japan and immuno-biochemical features of autoantibodies to factor VIII].
    Tanaka I, Shima N.
    Rinsho Ketsueki; 2005 Feb; 46(2):91-8. PubMed ID: 16447701
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Hemophilia A with factor VIII inhibitor].
    Shima M.
    Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Activated prothrombin complex concentrates in the management of the hemophiliac with Factor VIII inhibitor: case report.
    Griffen AL, Hoots WK, Carter AB.
    Pediatr Dent; 1987 Dec; 9(4):321-4. PubMed ID: 3148907
    [No Abstract] [Full Text] [Related]

  • 27. Current status and trends in the treatment of hemophilic patients with inhibitors.
    Bloom AL.
    Prog Clin Biol Res; 1981 Dec; 72():123-38. PubMed ID: 6801682
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of treatment with activated prothrombin complex concentrate (FEIBA) on factor VIII-antibody level.
    Lechner K, Nowotny C, Krinninger B, Zegner M, Deutsch E.
    Thromb Haemost; 1979 Feb 15; 40(3):478-85. PubMed ID: 425062
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The management of factor VIII inhibitors in non-hemophilic patients.
    Green D.
    Prog Clin Biol Res; 1984 Feb 15; 150():337-52. PubMed ID: 6431438
    [Abstract] [Full Text] [Related]

  • 34. [Advances in the field of hemophilia therapy].
    Loeliger EA, Veltkamp JJ.
    Ned Tijdschr Geneeskd; 1968 Sep 07; 112(36):1593-5. PubMed ID: 5680135
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effectiveness of a heated prothrombin complex concentrate in hemophiliacs with inhibitors.
    Mannucci PM, Mari D, Pareti FI.
    Thromb Haemost; 1987 Dec 18; 58(4):1090-1. PubMed ID: 3127920
    [No Abstract] [Full Text] [Related]

  • 37. [Long-term treatment of hemophilia A with plasma fractions].
    Mey U, Gaerisch F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970 Dec 18; 93(3):357-62. PubMed ID: 4195282
    [No Abstract] [Full Text] [Related]

  • 38. Transfusion support for haemophiliacs.
    Allain JP.
    Clin Haematol; 1984 Feb 18; 13(1):99-117. PubMed ID: 6426835
    [No Abstract] [Full Text] [Related]

  • 39. New approaches to using FEIBA in the treatment of inhibitor patients.
    Berntorp E, Gringeri A, Leissinger C, Négrier C, Key N.
    Semin Thromb Hemost; 2006 Jun 18; 32 Suppl 2():22-7. PubMed ID: 16804832
    [Abstract] [Full Text] [Related]

  • 40. Hemophilia.
    Aledort LM.
    N Engl J Med; 2001 Oct 04; 345(14):1066; author reply 1067. PubMed ID: 11586968
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.